NCT04193020 (ACID LTR) is a clinical trial of Surveillance card in Uveitis, sponsored by Wroclaw Medical University.

Who is sponsoring NCT04193020?

NCT04193020 is sponsored by Wroclaw Medical University.

What drugs are being tested in NCT04193020?

Interventions in NCT04193020: Surveillance card.

Is NCT04193020 still recruiting?

NCT04193020 is currently status unknown. Last updated 20 April 2021.

Last reviewed 2021-04-20 · How we verify

NCT04193020: ACID LTR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute and Chronic Inflammatory Disease, Lifestyle and Treatment Response

Status unknown Last updated 20 April 2021

What this trial tests

trial testing Surveillance card in Uveitis in 300 participants. Status unknown.

Timeline

1 January 2020

Primary endpoint
1 January 2025

1 January 2026

Quick facts

Lead sponsor	Wroclaw Medical University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 January 2020
Primary completion	1 January 2025
Estimated completion	1 January 2026
Sites	1 location across Poland

Drugs / interventions tested

Surveillance card

Conditions studied

Uveitis — all drugs for Uveitis →

Sponsor

Wroclaw Medical University

Who can join

Eligibility, any sex, with Uveitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute and chronic inflammatory eye diseases are difficult to diagnose and maintain quiescent with therapy. Proposed study is aimed to find on the one hand, novel factors for recurrence of the disease or remission of inflammation and evaluation of the impact of lifestyle and known factors on the other. Each patient is treated in accordance to the best of medical knowledge and guidelines for each disease. This prospective cohort study will enroll uveitic patients to the steroid only group (SG), combined (steroid and adjuvant drug) group (CG) or bilogic therapy group (BTG). At baseline, patient data are recorded using patient-reported outcome measures and clinical assessments (ophthalomology) on disease activity (clinical scales), quality of life, and lifestyle together with registry data on comorbidity and medication. During follow-up evaluation of a successful treatment outcome response will be based on clinical scales and most frequently used primary endpoints; the major outcome of the analyses will be to detect differences in treatment outcome between patients in different treatment group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Imbalance in PB IL-17-Secreting and Regulatory Cells in Pars Planitis Is Associated with Dysregulation of IFN-<i>γ</i>-Secreting Cells, Especially in Patients with Clinical Complications.
Kosmaczewska A, Przeździecka-Dołyk J, Turno-Kręcicka A, Ciszak L, et al · · 2020 · cited 2× · PMID 32801998 · DOI 10.1155/2020/9175083

Verify or expand the search:

Other recruiting trials for Uveitis

Currently open trials in the same condition.

NCT07262437 — Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles · NA · active not recruiting
NCT07176130 — Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore · active not recruiting
NCT06974162 — Metagenomics for Ocular Inflammation · recruiting
NCT06431373 — A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis · Phase 3 · active not recruiting
NCT06310837 — Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis · NA · active not recruiting

Other Wroclaw Medical University trials

Trials by the same sponsor.

NCT07413419 — Evaluation of Remote Motivational Interviewing for Disease Management in Heart Failure Patients and Their Carers · NA · not yet recruiting
NCT07159932 — Poland Integrated Medicines Management (PL-IMM) - Study Assessing the Provision of Complex Clinical Pharmacy Services to · NA · not yet recruiting
NCT07141745 — Electroporation vs. Radiofrequency Ablation Guided by 3D Imaging in Repeat Procedures for Atrial Fibrillation · NA · recruiting
NCT07099885 — Simple Urine Composition-based Personalized Algorithm for Effective Congestion Relief in Decompensated Heart Failure · NA · recruiting
NCT07157475 — Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04193020 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wroclaw Medical University
Last refreshed: 20 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04193020.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing